NCT07170371

Brief Summary

The goal of this clinical trial is to learn if a culturally adapted patient education program can help people with rheumatoid arthritis (RA) manage their disease and improve their quality of life. The main questions it aims to answer are:

  • Does the program improve patients' knowledge, self-management skills, and confidence in dealing with RA?
  • Does it lead to better quality of life and treatment adherence compared to usual care? Participants will:
  • Join group sessions and individual activities focused on RA education, self-care, and stress management
  • Take part in the program for 6 months, with regular follow-up visits
  • Complete questionnaires about symptoms, daily activities, and quality of life

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
88

participants targeted

Target at P50-P75 for not_applicable rheumatoid-arthritis

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable rheumatoid-arthritis

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

September 5, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 12, 2025

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2026

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2024

Enrollment Period

25 days

First QC Date

September 5, 2025

Last Update Submit

September 5, 2025

Conditions

Keywords

patient education

Outcome Measures

Primary Outcomes (1)

  • AIMS2 Quality of life

    Change in health-related quality of life among participants, measured using validated patient-reported questionnaires (AIMS2) to assess physical, emotional, and social domains. The focus is on improvement in self-reported well-being and daily functioning.

    Baseline to 6 months after randomization

Secondary Outcomes (4)

  • DAS-28

    Baseline to 6 months after randomization

  • ASES

    Baseline to 6 months after randomization

  • MARS

    Baseline to 6 months after randomization

  • BDI

    Baseline to 6 months after randomization

Study Arms (2)

Patient education Group

EXPERIMENTAL

A culturally adapted patient education program designed for individuals with rheumatoid arthritis. The program was developed through a structured needs assessment and based on established health behavior theories. It includes five core modules delivered over six months: understanding rheumatoid arthritis, monitoring disease activity, treatment strategies, nutrition, and stress management. Sessions combine group workshops and individual support, with interactive materials and practical exercises. The program aims to strengthen patients' knowledge, self-management skills, and quality of life compared to usual care.

Other: patient education

Usual care Group

ACTIVE COMPARATOR

patients will receive usual care only

Other: Usual Care

Interventions

A culturally adapted patient education program designed for individuals with rheumatoid arthritis. The program was developed through a structured needs assessment and based on established health behavior theories. It includes five core modules delivered over six months: understanding rheumatoid arthritis, monitoring disease activity, treatment strategies, nutrition, and stress management. Sessions combine group workshops and individual support, with interactive materials and practical exercises. The program aims to strengthen patients' knowledge, self-management skills, and quality of life compared to usual care.

Patient education Group

patients will receive usual care only

Usual care Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (≥18 years) diagnosed with rheumatoid arthritis according to ACR/EULAR 2010 classification criteria
  • Stable pharmacological treatment for at least 3 months prior to enrollment
  • Ability to participate in group sessions and complete questionnaires
  • Provided written informed consent

You may not qualify if:

  • Diagnosis of other systemic autoimmune or inflammatory rheumatic diseases (e.g., lupus, psoriatic arthritis)
  • Severe comorbidities that may interfere with participation (e.g., advanced heart failure, uncontrolled psychiatric illness)
  • Cognitive impairment or language barrier preventing comprehension of the program
  • Participation in another structured patient education program within the last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

university hospital IBN ROCHD

Casablanca, Morocco

Location

MeSH Terms

Conditions

Arthritis, Rheumatoid

Interventions

Patient Education as Topic

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Health EducationPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized into two parallel groups. One group will receive a culturally adapted patient education program in addition to usual medical care, while the other group will receive usual care alone. The two groups will be followed for 6 months, with comparative evaluation of outcomes related to self-management and quality of life.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr BOUNABE ABDELAAZI

Study Record Dates

First Submitted

September 5, 2025

First Posted

September 12, 2025

Study Start

September 5, 2025

Primary Completion

September 30, 2025

Study Completion

March 30, 2026

Last Updated

September 12, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations